Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule

NCT00307034 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: GSK Biologicals' 10-valent pneumococcal conjugate vaccine.
BIOLOGICAL: Infanrix hexa.
BIOLOGICAL: Infanrix-IPV/Hib.

Sponsor

GlaxoSmithKline